BGI Genomics Co Ltd (300676) — Long-term Investment Intensity
BGI Genomics Co Ltd (300676) has a Long-term Investment Intensity of 7.3% as of September 2019. Long-term investments of CN¥409.84 Million represent 7.3% of total assets of CN¥5.63 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 300676 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BGI Genomics Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how BGI Genomics Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 7.3%, reflecting long-term investments of CN¥409.84 Million against total assets of CN¥5.63 Billion CNY. Explore BGI Genomics Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for BGI Genomics Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for BGI Genomics Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BGI Genomics Co Ltd stock valuation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 5.4% | CN¥278.62 Million | CN¥5.13 Billion | ▲ +1.2 pp |
| 2017 | 4.3% | CN¥217.75 Million | CN¥5.11 Billion | ▲ +1.9 pp |
| 2016 | 2.4% | CN¥100.19 Million | CN¥4.23 Billion | ▲ +1.7 pp |
| 2015 | 0.7% | CN¥25.63 Million | CN¥3.91 Billion | — |